Hematologic Malignancy
Grade 3b Follicular Lymphoma
CI-CAN-00007775FLBCLExplore in graph →
Hematologic26 active trials
- NCIt
- C7192
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007775FLBCLExplore in graph →
Clinical trials
40 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (5)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05733650 | Expanded Access Program for Epcoritamab | approved for marketing | — | — | GenmabINDUSTRY | 0 | May 25, 2023 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2023source: clinicaltrials